A vaccine biotech firm based in Massachusetts points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.
A live-attenuated virus is a weakened (attenuated) virus that is able to multiply within the host to a limited extent and engineered to be unable to cause any disease.
Live-Attenuated Virus Vaccine Development ‘is the Right Approach'
Live-Attenuated Virus Vaccine Development 'is the Right Approach'
A vaccine biotech firm based in Massachusetts points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.
A live-attenuated virus is a weakened (attenuated) virus that is able to multiply within the host to a limited extent and engineered to be unable to cause any disease.
Russia’s COVID-19 Vaccine Development Plans Are Extensive
In addition to the two coronavirus vaccines that have already been registered by the Russian Federation, another twenty-four COVID-19 vaccine candidates were reported by Interfax to be in various stages of development.
Inna Kulikova, the director of the Russian Health Ministry's Department of Emergency Medical Care and Health Risk Management, stated at the Medicine and Quality 2020 conference held on December 8, 2020, "The Health Ministry of the Russian Federation registered the Gam-Covid-Vac (Sputnik V) vaccine on August 11, 2020, and the EpiVacCorona vaccine two months later.”
Russia's COVID-19 Vaccine Development Plans Are Extensive
In addition to the two coronavirus vaccines that have already been registered by the Russian Federation, another twenty-four COVID-19 vaccine candidates were reported by Interfax to be in various stages of development.
Inna Kulikova, the director of the Russian Health Ministry's Department of Emergency Medical Care and Health Risk Management, stated at the Medicine and Quality 2020 conference held on December 8, 2020, "The Health Ministry of the Russian Federation registered the Gam-Covid-Vac (Sputnik V) vaccine on August 11, 2020, and the EpiVacCorona vaccine two months later.”
Hospitalization Up for Black Gynecologic Cancer Patients With COVID-19
Among patients with gynecologic cancer who died from COVID-19, 41.2 percent were Black
Metformin Use May Reduce Mortality in Women With COVID-19
In overall sample of men and women, metformin use was not linked to significantly reduced mortality
Canada Approves Pfizer COVID-19 Vaccine
Health Canada completed a full independent review of the data on the vaccine’s safety and effectiveness
U.S. Hospitals Running Out of ICU Beds for COVID-19 Patients
Hospitals serving more than 100 million Americans had less than 15 percent of intensive care beds still available as of last week
COVID-19 Vaccine Caution Issued by U.K. Officials
Warning issued after two people suffered adverse reactions on the first day of the U.K. mass vaccination program